Supplemental material
Leukemia & Lymphoma
Volume 64, 2023 - Issue 11
Open access
1,088
Views
1
CrossRef citations to date
0
Altmetric
Original Articles
Healthcare resource utilization and costs during first salvage therapy for relapsed or refractory acute myeloid leukemia in the United States
Lori Mufflya Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA, USAView further author information
, Christopher Youngb Astellas Pharma, Inc, Northbrook, IL, USAView further author information
, Qi Fengb Astellas Pharma, Inc, Northbrook, IL, USAView further author information
, David Nimkeb Astellas Pharma, Inc, Northbrook, IL, USAView further author information
& Bhavik J. Pandyab Astellas Pharma, Inc, Northbrook, IL, USACorrespondence[email protected]
View further author information
View further author information
Pages 1832-1839
|
Received 09 Jan 2023, Accepted 05 Jul 2023, Published online: 24 Jul 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.